🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for MTA

JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation NCT06416410Phase 337 sites📍 Hefei📍 Beijing📍 Beijing Allist Pharmaceuticals, Inc. · Tests: JAB-21822, Tislelizumab, JAB-3312, Pemetrexed, Carboplatin Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas NCT05681195Phase 21 site📍 Miami Baptist Health South Florida · Tests: Pemetrexed, Zanubrutinib, Autologous Stem Cell Transplant (ASCT), Whole Brain Radiation Therapy (WBRT) Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC NCT03872661Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: IBI308, Bevacizumab, Pemetrexed, Carboplatin, Thoracic surgery BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079Phase 117 sites📍 Los Angeles📍 Sacramento📍 San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · Tests: BBO-11818, Pembrolizumab, Platinum chemotherapy (cisplatin or carboplatin), Pemetrexed, Cetuximab Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC NCT07405190Phase 23 sites📍 Boston📍 Boston📍 Boston Massachusetts General Hospital · Tests: Ivonescimab, carboplatin, pemetrexed Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars NCT06640205NA1 site📍 Cairo Future University in Egypt · Tests: pulpotomy A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC NCT06627647Phase 3301 sites📍 Mobile📍 Chandler📍 Phoenix AstraZeneca · Tests: Rilvegostomig, Pembrolizumab, Carboplatin, Cisplatin, Pemetrexed Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis NCT06643000NA2 sites📍 Zhengzhou📍 Zhengzhou Henan Cancer Hospital · Tests: furmonertinib Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC NCT05805631Phase 21 site📍 Taipei Taipei Veterans General Hospital, Taiwan · Tests: Pemetrexed A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib NCT06378892Phase 29 sites📍 Aviano📍 Florence📍 Lido di Camaiore Centro di Riferimento Oncologico - Aviano · Tests: Lorlatinib Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC NCT06663306Phase 11 site📍 Shanghai Shanghai Chest Hospital · Tests: Pemetrexed, Bevacizumab To Evaluate and Compare the Effect of Orthograde and Retrograde MTA Root End Filling After Periapical Surgery in Posteriors NCT07808424NA1 site📍 Rohtak Postgraduate Institute of Dental Sciences Rohtak · Tests: Endodontic Micro-Surgery, Endodontic Micro-Surgery Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma NCT07234058Phase 237 sites📍 Aix-en-Provence📍 Amiens📍 Angers Intergroupe Francophone de Cancerologie Thoracique · Tests: Cemiplimab, Fianlimab, Pemetrexed (Alimta), Cisplatin, Carboplatin (AUC 5) Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites📍 Shanghai📍 Shanghai📍 Chengdu Ruijin Hospital · Tests: Ivonescimab Combined With Chemotherapy A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer NCT07005102Phase 2, Phase 365 sites📍 Chandler📍 Duarte📍 Irvine AbbVie · Tests: Standard of Care, Telisotuzumab Adizutecan, Osimertinib (Osi), Cisplatin, Carboplatin Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer NCT06755684Phase 21 site📍 Shanghai Peng Zhang · Tests: Befotertinib combined Bevacizumab, Befotertinib combined platinum-based double chemotherapy Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma NCT07744529Phase 1, Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Amivantamab+ systemic/ intrathecal Pemetrexed Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) NCT07100080Phase 2, Phase 3187 sites📍 Irvine📍 Orange📍 Edwards Bristol-Myers Squibb · Tests: Iza-bren, Carboplatin, Cisplatin, Pemetrexed Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC NCT07777822Phase 31 site📍 Plantation Revolution Medicines, Inc. · Tests: zoldonrasib, Placebo, pembrolizumab, pemetrexed + cisplatin /carboplatin Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol NCT06288477NA1 site📍 El-Sheikh Zayed City October University for Modern Sciences and Arts · Tests: A cotton pellet moistened with full-strength FC, Neo-Putty A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer NCT06119581Phase 3416 sites📍 Huntsville📍 Gilbert📍 Phoenix Eli Lilly and Company · Tests: LY3537982, Pembrolizumab, Placebo, Cisplatin, Carboplatin Bioceramic Putty Versus MTA in Pulpotomized Primary Teeth to be Covered With 3D Printed Resin Crowns Versus Stainless Steel Crown NCT07344038NA1 site📍 Alexandria Alexandria University · Tests: Endo-sequence bioceramic putty pulpotomy, Bio MTA+ pulpotomy, Stainless Steel Crowns (SSCs), 3D-Printed Resin Crowns A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) NCT07190248Phase 3221 sites📍 Birmingham📍 Farmington📍 Stamford Merck Sharp & Dohme LLC · Tests: Calderasib, Pembrolizumab (+) Berahyaluronidase alfa, Pemetrexed, Cisplatin, Carboplatin A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma NCT05456256Phase 216 sites📍 Beverly Hills📍 Fountain Valley📍 Los Alamitos Lantern Pharma Inc. · Tests: LP-300, Pemetrexed, Carboplatin Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib. NCT06296745Phase 21 site📍 Huizhou Guangzhou Medical University · Tests: Pemetrexed Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases NCT06440954Phase 21 site📍 Changsha Hunan Province Tumor Hospital · Tests: Intrathecal pemetrexed Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM NCT06543069Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Sintilimab, Bevacizumab , Pemetrexed , Cisplatin Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC NCT07098988Phase 251 sites📍 Birmingham📍 Los Angeles📍 Derby CatalYm GmbH · Tests: Visugromab, Matching placebo for visugromab, Pembrolizumab 200 mg Q3W, Pemetrexed 500 mg/m^2, Carboplatin AUC 5 High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI NCT06652048Phase 21 site📍 Shanghai Jialei Wang · Tests: Furmonertinib 160mg QD, Furmonertinib 240mg QD, Furmonertinib 160mg QD plus Chemotherapy Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases NCT07092202Phase 41 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Firmonertinib, Intrathecal injection of pemetrexed
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy